NEWS COMMENTARY

Researchers at Swiss Federal Institute of Technology Lausanne developing digital biomarker for COVID-19 based on cough sounds

Published:
April 23, 2020
Services:
Consumer
Activities:
Project
by Danielle Bradnan
Very important

The Embedded Systems Laboratory is developing a digital biomarker to be used for the diagnosis of COVID-19 based on cough sounds collected from a smartphone speaker. Cough sounds have long been used in diagnosing respiratory diseases, and more recently, the use of computer vision coupled with sensors in mobile devices has allowed for the development of digital endpoints for clinical trials, such as by the company HealthMode. Digital biomarkers are an emerging technology that allows for earlier and more personalized diagnostics, and clients should be looking invest in this technology as an accompaniment to current digital health offerings like wearables, digital therapeutics, and telehealth services.

For the original news article, click here .


Further Reading

In collaboration with Apple, Biogen announces study collecting digital biomarkers for cognitive decline

News Commentary | February 17, 2021

This pilot study announcement lacks details on the feasibility of developing these digital biomarkers and raises issues about how the study will be conducted. There are major privacy concerns associated with sending detailed reports on device usage, and it remains to be seen how Apple will ... Not part of subscription

LetsGetChecked raises $150 million Series D round to expand at-home testing platform

News Commentary | June 17, 2021

The round was led by Casdin Capital, and the company plans to use the funds to develop Care Pathways, a "360‑degree" customer care journey initiative that serves to integrate its diagnostic tests, pharmacy, and telehealth capabilities. The service will enable asynchronous video and chat ... Not part of subscription

Otsuka Pharmaceutical and virtual reality (VR) startup Jolly Good partner on a JPY 5 billion deal to support psychiatric disorders

News Commentary | February 10, 2022

Otsuka inked an apparently strong JPY 5 billion deal with local VR developer Jolly Good to develop social skill training VR systems to socially rehabilitate patients with psychiatric disorders. Otsuka has a big psychiatry portfolio and values the impact of digital therapeutics (DTx), with a number ... Not part of subscription